Metabolic implications of GH treatment in small for gestational age

European Journal of Endocrinology

Volumn 157, Issue SUPPL. 1, 2007, Pages

  Delemarre, E M ^b   Rotteveel, J ^a   Delemarre van de Waal, H A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; GLUCOSE; GROWTH HORMONE; INSULIN; LIPID; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ABDOMINAL FAT; BODY HEIGHT; CARBOHYDRATE METABOLISM; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; DYSLIPIDEMIA; GLUCONEOGENESIS; GLUCOSE METABOLISM; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; GROWTH RETARDATION; HUMAN; HYPERINSULINEMIA; HYPERTENSION; HYPOGLYCEMIA; INSULIN METABOLISM; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAUTERINE GROWTH RETARDATION; LIPID METABOLISM; LIPOLYSIS; LOW BIRTH WEIGHT; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMALL FOR DATE INFANT; TURNER SYNDROME;

BODY HEIGHT; GLUCOSE; GROWTH DISORDERS; GROWTH HORMONE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; INSULIN; LIPID METABOLISM;

EID: 34548751153     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/EJE-07-0163     Document Type: Review

References (29)

1. Randle PJ, Garland PB, Hales CN & Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963 1 785-789.
2. Möller N, Jörgensen JO, Schmitz O, Möller J, Christiansen J, Alberti KG & Orskov H. Effects of a growth hormone pulse on total and forearm substrate fluxes in humans. American Journal of Physiology 1990 258 E86-E91.
3. Moller N, Schmitz O, Porksen N, Moller J & Jorgensen JO. Dose-response studies on the metabolic effects of a growth hormone pulse in humans. Metabolism 1992 41 172-175.
4. Pal BR, Matthews DR, Edge JA, Mullis PE, Hindmarsh PC & Dunger DB. The frequency and amplitude of growth hormone secretory episodes as determined by deconvolution analysis are increased in adolescents with insulin dependent diabetes mellitus and are unaffected by short-term euglycaemia. Clinical Endocrinology 1993 38 93-100.
5. Pal BR, Phillips PE, Matthews DR & Dunger DB. Contrasting metabolic effects of continuous and pulsatile growth hormone administration in young adults with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1992 35 542-549.
6. Ho KY, Veldhuis JD, Johnson ML, Furlanetto R, Evans WS, Alberti KG & Thorner MO. Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man. Journal of Clinical Investigation 1988 81 968-975.
7. Pimstone B. Endocrine function in protein-calorie malnutrition. Clinical Endocrinology 1976 5 79-95.
8. Angeletti G. The metabolic complications of acromegaly. Journal of Endocrinology Investigation 2003 26 18-19.
9. Beshyah SA, Henderson A, Niththyananthan R, Skinner E, Anyaoku V, Richmond W, Sharp P & Johnston DG. The effects of short and long-term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance. Journal of Clinical Endocrinology and Metabolism 1995 80 356-363.
10. Simpson HL, Jackson NC, Shojaee-Moradie F, Jones RH, Russell-Jones DL, Sönksen PH, Dunger DB & Umpleby AM. Insulin-like growth factor I has a direct effect on glucose and protein metabolism, but no effect on lipid metabolism in type 1 diabetes. Journal of Clinical Endocrinology and Metabolism 2004 89 425-432.
11. Hwa V, Oh Y & Rosenfeld RG. The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocrine Reviews 1999 20 761-787.
12. Clayton PE, Cianfarani S, Czernichow P, Johannsson G, Rapaport R & Rogol A. Management of the child born small for gestational age through to adulthood: A Consensus Statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society. Journal of Clinical Endocrinology and Metabolism 2007 92 804-810.
13. Barker DJ. The developmental origins of chronic adult disease. Acta Paediatrica 2004 93 26-33.
14. Tenhola S, Halonen P, Jaaskelainen J & Voutilainen R. Serum markers of GH and insulin action in 12-year-old children born small for gestational age. European Journal of Endocrinology 2005 152 335-340.
15. Soto N, Bazaes RA, Pena V, Salazar T, Avila A, Iñiguez G, Ong KK, Dunger DB & Mericq MV. insulin sensitivity and secretion are related to catch-up growth in smalt-for-gestational-age infants at age 1 year: results from a prospective cohort. Journal of Clinical Endocrinology and Metabolism 2003 88 3645-3650.
16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF & Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 412-419.
17. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G & Quon MJ. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. Journal of Clinical Endocrinology and Metabolism 2000 85 2402-2410.
18. DeFronzo RA, Tobin JD & Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. American Journal of Physiology 1979 237 E214-E223.
19. Efendic S, Cerasi E & Luft R. Role of glucose in arginine-induced insulin release in man. Metabolism 1971 20 568-579.
20. Veening MA, van Weissenbruch MM & Delemarre-van de Waal HA. Glucose tolerance, insulin sensitivity, and insulin secretion in children born small for gestational age. Journal of Clinical Endocrinology and Metabolism 2002 87 4657-4661.
21. Huxley RR, Shiell AW & Law CM. The role of size at birth and postnatal catch-up growth in determining systolic blood pressure: a systematic review of the literature. Journal of Hypertension 2000 18 815-831.
22. van Assche FA & Aerts L. The fetal endocrine pancreas. Contributions in Gynecology and Obstetrics 1979 5 44-57.
23. Garofano A, Czernichow P & Breant B. Beta-cell mass and proliferation following late fetal and early postnatal malnutrition in the rat. Diabetologia 1998 41 1114-1120.
24. Veening MA, van Weissenbruch MM, Heine RJ & Delemarre-van de Waal HA. Beta-cell capacity and insulin sensitivity in prepubertal children born small for gestational age: influence of body size during childhood. Diabetes 2003 52 1756-1760.
25. Clayton PE, Cianfarani S, Czernichow P, Johannsson G, Rapaport R & Rogol A. Management of the child born small for gestational age through to adulthood: A Consensus Statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society. Journal of Clinical Endocrinology and Metabolism 2007 92 804-810.
26. Sas T, Muinck Keizer-Schrama S, Aanstoot HJ, Stijnen T & Drop S. Carbohydrate metabolism during growth hormone treatment and after discontinuation of growth hormone treatment in girls with Turner syndrome treated with once or twice daily growth hormone injections. Clinical Endocrinology 2000 52 741-747.
27. Sas T, Mulder P, Aanstoot HJ, Houdijk M, Jansen M, Reeser M & Hokken-Koelega A. Carbohydrate metabolism during long-term growth hormone treatment in children with short stature born small for gestational age. Clinical Endocrinology 2001 54 243-251.
28. Cutfield WS, Lindberg A, Rapaport R, Wajnrajch MP & Saenger P. Safety of growth hormone treatment in children born small for gestational age: the US trial and KIGS analysis. Hormone Research 2006 65 153-159.
29. van Dijk M, Bannink EM, van Pareren YK, Mulder PG & Hokken-Koelega AC. Risk factors for diabetes mellitus type 2 and metabolic syndrome are comparable for previously growth hormone-treated young adults born small for gestational age (sga) and untreated short SGA controls. Journal of Clinical Endocrinology and Metabolism 2007 92 160-165.